About
Andrew Abrams is a Partner at New Science Ventures, which he joined as an Associate in September 2016 before becoming Partner in July 2020. He previously worked as an Associate in J.P. Morgan's healthcare investment banking practice in London, advising biotechnology, pharmaceutical, medical device, diagnostic and service clients on M&A and equity transactions across Europe and the U.S. He holds B.A., M.A. and M.Sci. degrees in Natural Sciences and Biochemistry from the University of Cambridge and an M.B.A. from Harvard Business School.
Invests in
Biotech
Investments
Board seats
MorrowNovadip BiosciencesParadigm DiagnosticsTrellis BioscienceVimalan Biosciences
Per the firm's website.
